253 related articles for article (PubMed ID: 31074246)
1. Prognostic importance of atypical endometriosis with architectural hyperplasia versus cytologic atypia in endometriosis-associated ovarian cancer.
Ñiguez Sevilla I; Machado Linde F; Marín Sánchez MDP; Arense JJ; Torroba A; Nieto Díaz A; Sánchez Ferrer ML
J Gynecol Oncol; 2019 Jul; 30(4):e63. PubMed ID: 31074246
[TBL] [Abstract][Full Text] [Related]
2. Pelvic endometriosis is rarely associated with ovarian borderline tumours, cytologic and architectural atypia: a clinicopathologic study.
Bedaiwy MA; Hussein MR; Biscotti C; Falcone T
Pathol Oncol Res; 2009 Mar; 15(1):81-8. PubMed ID: 18575828
[TBL] [Abstract][Full Text] [Related]
3. Prognostic importance of hyperplasia and atypia in endometriosis.
Seidman JD
Int J Gynecol Pathol; 1996 Jan; 15(1):1-9. PubMed ID: 8852439
[TBL] [Abstract][Full Text] [Related]
4. Targeted next-generation sequencing for molecular diagnosis of endometriosis-associated ovarian cancer.
Er TK; Su YF; Wu CC; Chen CC; Wang J; Hsieh TH; Herreros-Villanueva M; Chen WT; Chen YT; Liu TC; Chen HS; Tsai EM
J Mol Med (Berl); 2016 Jul; 94(7):835-47. PubMed ID: 26920370
[TBL] [Abstract][Full Text] [Related]
5. Endometriosis-associated ovarian cancer: a clinicopathologic review.
Steed H; Chapman W; Laframboise S
J Obstet Gynaecol Can; 2004 Aug; 26(8):709-15. PubMed ID: 15307975
[TBL] [Abstract][Full Text] [Related]
6. Endometriosis-associated ovarian carcinoma (EAOC): an entity distinct from other ovarian carcinomas as suggested by a nested case-control study.
Erzen M; Rakar S; Klancnik B; Syrjänen K
Gynecol Oncol; 2001 Oct; 83(1):100-8. PubMed ID: 11585420
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of Endometriosis in Malignant Epithelial Ovarian Tumor.
Akbarzadeh-Jahromi M; Shekarkhar G; Sari Aslani F; Azarpira N; Heidari Esfahani M; Momtahan M
Arch Iran Med; 2015 Dec; 18(12):844-8. PubMed ID: 26621017
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics and serum CA19-9 combined with HE4 are valuable in diagnosing endometriosis-associated ovarian cancer.
Xu T; Zhang L; Jiang Y; Wan Y; Zhou S; Sun G; Cheng W; Yuan L
Int J Gynaecol Obstet; 2023 Aug; 162(2):472-478. PubMed ID: 36708088
[TBL] [Abstract][Full Text] [Related]
9. Does Endometriosis Hinder Successful Ovarian Debulking Surgery?
Sananpanichkul P; Muangtan S; Suknikhom W; Bhamarapravatana K; Suwannarurk K
Asian Pac J Cancer Prev; 2018 Feb; 19(2):509-512. PubMed ID: 29480993
[TBL] [Abstract][Full Text] [Related]
10. The oncofetal protein IMP3: a novel biomarker and triage tool for premalignant atypical endometriotic lesions.
Vercellini P; Cribiù FM; Del Gobbo A; Carcangiu ML; Somigliana E; Bòsari S
Fertil Steril; 2013 Jun; 99(7):1974-9. PubMed ID: 23473990
[TBL] [Abstract][Full Text] [Related]
11. [Risk factors of endometriosis associated ovarian carcinoma in women aged 45 years and older].
He ZX; Wang S; Li ZF; Zhu L; Leng JH; Lang JH
Zhonghua Fu Chan Ke Za Zhi; 2017 May; 52(5):314-319. PubMed ID: 28545269
[No Abstract] [Full Text] [Related]
12. Histopathology and ARID1A Expression in Endometriosis- Associated Ovarian Carcinoma (EAOC) Carcinogenesis Model with Endometrial Autoimplantation and DMBA Induction.
Wuyung PE; Rahadiati FB; Tjahjadi H; Salinah S; Kusmardi K; Kodariah R; Wiweko B
Asian Pac J Cancer Prev; 2021 Feb; 22(2):553-558. PubMed ID: 33639673
[TBL] [Abstract][Full Text] [Related]
13. Endometriosis-associated ovarian carcinoma: differential expression of vascular endothelial growth factor and estrogen/progesterone receptors.
Del Carmen MG; Smith Sehdev AE; Fader AN; Zahurak ML; Richardson M; Fruehauf JP; Montz FJ; Bristow RE
Cancer; 2003 Oct; 98(8):1658-63. PubMed ID: 14534882
[TBL] [Abstract][Full Text] [Related]
14. Cancer Implications for Patients with Endometriosis.
Wilbur MA; Shih IM; Segars JH; Fader AN
Semin Reprod Med; 2017 Jan; 35(1):110-116. PubMed ID: 28049216
[TBL] [Abstract][Full Text] [Related]
15. Establishment of a novel model of endometriosis-associated ovarian cancer by transplanting uterine tissue from Arid1a/Pten knockout mice.
Ono M; Miyamoto T; Asaka R; Uchikawa J; Ando H; Tanaka Y; Shinagawa M; Yokokawa Y; Asaka S; Wang TL; Shih IM; Shiozawa T
Sci Rep; 2023 May; 13(1):8348. PubMed ID: 37221199
[TBL] [Abstract][Full Text] [Related]
16. Endometriosis-associated Ovarian Cancer is a Subset With a More Favorable Outcome and Distinct Clinical-pathologic Characteristics.
Bassiouny D; El-Baz MA; Gamil TM; Shams N; Ismiil N; Dubé V; Han G; Cesari M; Lu FI; Slodkowska E; Chiu HF; Naeim M; Li N; Nofech-Mozes S; Khalifa MA
Int J Gynecol Pathol; 2019 Sep; 38(5):435-442. PubMed ID: 30059454
[TBL] [Abstract][Full Text] [Related]
17. The ARID1A pathway in ovarian clear cell and endometrioid carcinoma, contiguous endometriosis, and benign endometriosis.
Chene G; Ouellet V; Rahimi K; Barres V; Provencher D; Mes-Masson AM
Int J Gynaecol Obstet; 2015 Jul; 130(1):27-30. PubMed ID: 25912412
[TBL] [Abstract][Full Text] [Related]
18. Atypical Endometriosis: Comprehensive Characterization of Clinicopathologic, Immunohistochemical, and Molecular Features.
Wepy C; Nucci MR; Parra-Herran C
Int J Gynecol Pathol; 2024 Jan; 43(1):70-77. PubMed ID: 37043650
[TBL] [Abstract][Full Text] [Related]
19. Endometriosis-associated ovarian cancer occurs early during follow-up of endometrial cysts.
Murakami K; Kotani Y; Shiro R; Takaya H; Nakai H; Matsumura N
Int J Clin Oncol; 2020 Jan; 25(1):51-58. PubMed ID: 31473885
[TBL] [Abstract][Full Text] [Related]
20. A histologic study of ovarian endometriosis with emphasis on hyperplastic and atypical changes.
Czernobilsky B; Morris WJ
Obstet Gynecol; 1979 Mar; 53(3):318-23. PubMed ID: 424103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
